G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/569 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2262066
The invention provides a rapid, sensitive immunoassay capable of detecting and quantitating pathogenic protein to a level of 3 to 5 logs. The preferred immunoassay utilized is a chemiluminescent endpoint for a Western blot immunoassay. The invention has been successfully applied to track the clearance of pathogenic protein during production of proteins derived from plasma, It is particularly applicable and has been confirmed by bioassay to relate TSE infectivity to quantitative results on prion protein
Kozak Robert W.
Lee Douglas C.
Petteway Steve R.
Bayer Healthcare Llc
Borden Ladner Gervais Llp
Corporation Bayer
LandOfFree
Rapid method of determining clearance of prion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid method of determining clearance of prion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid method of determining clearance of prion protein will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1594386